Filtros de búsqueda

Lista de obras de

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 07 September 2018

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.

artículo científico publicado en 2015

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

scientific article published on 22 March 2020

Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers ⬇️

artículo científico publicado el 5 de agosto de 2011

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy - early promise but more data needed. Authors' reply

scientific article published on 01 March 2019

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.

artículo científico publicado en 2015

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

artículo científico publicado en 2017

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

artículo científico publicado en 2020

Incontinence in full‐thickness rectal prolapse: low level of improvement after laparoscopic rectopexy ⬇️

artículo científico publicado el 1 de abril de 2013

Intestinal steroidogenesis

artículo científico

Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis

scientific article published on 22 July 2014

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

artículo científico publicado en 2018

MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease

artículo científico publicado en 2015

No Surgery for Full‐Thickness Rectal Prolapse: What Happens with Continence? ⬇️

artículo científico publicado el 1 de junio de 2013

Outcomes of upper gastrointestinal bleeding are similar between direct oral anticoagulants and vitamin K antagonists

scientific article published on 05 January 2021

Portomesenteric Vein Thrombosis in Patients With Inflammatory Bowel Disease ⬇️

artículo científico publicado el 1 de marzo de 2013

Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring

artículo científico publicado en 2019

Prevalence and predictive factors of the need for surgery for advanced colorectal adenoma ⬇️

artículo científico publicado el 1 de junio de 2013

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 02 August 2018

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

artículo científico publicado en 2020

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

artículo científico publicado en 2015

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

artículo científico publicado en 2019

Treat to target: a proposed new paradigm for the management of Crohn's disease

artículo científico

Underlying functional bowel disorder may explain patient dissatisfaction after haemorrhoidal surgery ⬇️

artículo científico publicado el 1 de marzo de 2012

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

artículo científico publicado en 2019

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients

scientific article published on 20 February 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda